DLACX
Price
$13.27
Change
-$0.74 (-5.28%)
Updated
Apr 3 closing price
Net Assets
179.67M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

DLACX vs GFACX

Header iconDLACX vs GFACX Comparison
Open Charts DLACX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity Y
Price$13.27
Change-$0.74 (-5.28%)
VolumeN/A
Net Assets179.67M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
DLACX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLACX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLACX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. DLACX (180M). DLACX pays higher dividends than GFACX: DLACX (0.59) vs GFACX (0.00). DLACX was incepted earlier than GFACX: DLACX (10 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than DLACX (0.77). DLACX is a more actively managed with annual turnover of: 39.80 vs. GFACX (25.00). GFACX has a lower initial minimum investment than DLACX: GFACX (250) vs DLACX (1000000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. DLACX (-18.50). GFACX return over 5 years is better than : 59.73 vs. DLACX (-14.12).
DLACXGFACXDLACX / GFACX
Total Expense Ratio0.751.3655%
Annual Report Gross Expense Ratio0.771.3657%
Fund Existence10 years24 years-
Gain YTD-5.784-5.003116%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets180M280B0%
Annual Yield % from dividends0.590.00-
Returns for 1 year-18.50-1.751,056%
Returns for 3 years-45.670.63-7,233%
Returns for 5 years-14.1259.73-24%
Returns for 10 yearsN/A44.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences